|
Sagent Pharmaceuticals, Inc. to present at CIBC world markets 18th annual healthcare conference
|
|
|
|
|
Sunday, 28 October 2007
|
|
SCHAUMBURG, IL. Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company with a focus on injectable products today announced that Ronald E. Pauli, chief financial officer, will present at the CIBC World Markets 18th Annual Healthcare Conference in New York on Tuesday, November 6 at 10:55 a.m.
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, founded in 2006, is a privately held specialty
pharmaceutical company focused on developing, manufacturing, sourcing
and marketing pharmaceutical products, with a specific focus on
injectable products. Sagent has created a unique, global network of
resources, comprised of rapid development capabilities, sophisticated
manufacturing and innovative drug-delivery technologies, quickly
yielding an extensive portfolio of pharmaceutical products that
fulfills the evolving needs of patients. Sagent currently has more
than 200 products in development.
For more information about the company and its products, please visit www.sagentpharma.com.
INVESTOR CONTACT:
Ron Pauli, Sagent
(847) 908-1604 |
MEDIA CONTACT:
Geoff Curtis, WeissComm Partners
(312) 284-4701 |
|
|
